Literature DB >> 12724700

Vasoproliferative tumours of the retina.

K Jain1, A R Berger, Y H Yucil, H D McGowan.   

Abstract

This paper describes three cases of vasoproliferative tumours of the retina including histopathology in one. The clinical presentation, differential diagnosis and treatment modalities are discussed with a brief review of the literature.

Entities:  

Mesh：

Year:  2003        PMID： 12724700     DOI： 10.1038/sj.eye.6700311

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


  6 in total

1.  [Histological findings in bilateral asymmetrical vasoproliferative retinal tumor].

Authors:  S Bajorat; S Koinzer; J H Bräsen; H H Hugo; J Roider
Journal:  Ophthalmologe       Date:  2012-10       Impact factor: 1.059

2.  Macular Hole Formation in Eye After Cryotherapy and Intravitreal Bevacizumab Treatment for Vasoproliferative Tumor.

Authors:  Atsuko Sato; Emi Fukui; Kouichi Ohta
Journal:  Int Med Case Rep J       Date:  2020-09-14

3.  Ruthenium-106 plaque brachytherapy for symptomatic vasoproliferative tumours of the retina.

Authors:  G Anastassiou; N Bornfeld; A O Schueler; H Schilling; S Weber; D Fluehs; B Jurklies; O Vij; W Sauerwein
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

4.  Retinal vasoproliferative tumour-induced intractable neovascular glaucoma in a child with neurofibromatosis type 1.

Authors:  Deepika C Parameswarappa; Abhilasha Arvind Alone; Padmaja Kumari Rani
Journal:  BMJ Case Rep       Date:  2020-08-26

5.  Case Report: Exacerbation and Spontaneous Separation of the Epiretinal Membrane Following Laser Photocoagulation of a Vasoproliferative Tumor of the Retina.

Authors:  Luyao Tong; Yujie Jia; Junliang Wang; Yan Li; Zhiqing Chen; Shelan Liu; Li Zhang
Journal:  Front Med (Lausanne)       Date:  2022-02-25

6.  Retinal vasoproliferative tumor - A proposal for classification.

Authors:  Santosh G Honavar
Journal:  Indian J Ophthalmol       Date:  2018-02       Impact factor: 1.848
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.